Skip to main content
. 2020 Apr 19;10(8):1453–1475. doi: 10.1016/j.apsb.2020.04.002

Table 2.

VEGFR2/FGFR1/PDGFRβ inhibition of the typical compounds B1B3 obtained by R2 group optimization.Image 14

Compd. Structure or R2 IC50 (nmol/L)


VEGFR2 FGFR1 PDGFRβ
Lead compd. CH3 9.4 188.0 143.0
B1 Image 15 335.2 9032.0 388.9
B2 Image 16 26.7 216.4 56.9
B3 Image 17 226.8 777.1 409.8